Top 5 Clinical Trials Shaping Medicine in 2025
From precision oncology to gene editing, these standout trials could redefine how to diagnose and treat rare diseases and cancer
Inside the Diagnostics Industry-dtet
Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge
The pandemic may have set the stage for a jump in infections from these four nemeses
Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry
From - Diagnostic Testing & Emerging Technologies
For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine…
New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending
From - Diagnostic Testing & Emerging Technologies
As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by…
Diagnostic danger in the lab: Time to reform how we process orders
Recent report examining 10,000 claims to understand the key drivers of medical malpractice suits found 52 percent involved lab-related errors.
Tests Emerging to Advance Cardiovascular Risk Assessment
From - Diagnostic Testing & Emerging Technologies
While testing for cardiovascular conditions does not garner the headlines that oncology testing does, several recent studies demonstrate how the introduction of genetic testing and…
Outreach Survey Focuses on Clinical Laboratory Industry Trends Amidst Greatest Disruption in Three Decades
By Jeff Myers bio
Accumen Inc. is pleased to announce the launch of the 17th Annual National Hospital and Health System Laboratory and Outreach Survey. The survey is designed to capture intelligence on…
Diagnostics Industry Responding to Opioid Epidemic
From - Diagnostic Testing & Emerging Technologies
Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or…
Curetis to Launch Multiplex MDx for Hospital Infections in U.S.
From - Diagnostic Testing & Emerging Technologies
Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized…